There will be over a hundred French companies reasserting their interest in the Near and Middle Eastern health market as they join the French national pavilion led by UBIFRANCE – the French Agency for business development – at ARAB HEALTH and MEDLAB in Dubai from next January 23rd to 26th.
Demand in Near and Middle East countries remains very high in terms of health, thanks to government investments, to the liberalisation of the private sector and to high demographic growth. This growth, coupled with a significant reliance on imports, is encouraging French companies to position themselves on this market. Accordingly, France is among the top five suppliers to the area.
Confronted with increasing health and economic challenges, the French biotechnology and medical systems sector remains a world leader thanks to its unrelenting R&D and to a very close working relationship between industrialists and medico-surgical teams. The competitiveness clusters that have appeared over the past few years have fostered those synergies have given France the ability to maintain the kind of dynamism that ranks it among the top suppliers in the region.
This year the French pavilion will be hosting over thirty new participants, demonstrating the renewal occurring within the French offer. The offer stands out through significant innovation, a wide diversity and quality equipment. One will see several sectors of excellence at ARAB HEALTH: in-vitro diagnosis, devices and equipment for cardio-vascular surgery and orthopaedics and much more. Over recent years, French companies have committed substantial investments to other sectors like ultrasound or have focused their development on telemedicine or home assistance, and they will be showing highly innovative solutions in those fields at ARAB HEALTH 2012. Also, a dozen companies will be exhibiting at MEDLAB, where the focus is instrumentation and laboratory equipment.
Gathered by UBIFRANCE, French exhibitors can be seen in Zabeel Hall and Rashid Hall at ARAB HEALTH.
Some French companies are introducing new technologies in the health sector as :
Capsule, a French company, the leading global provider of medical device connectivity, today announced plans to expand its connectivity offering in Europe and the Middle East Regions. Building on their record growth in 2010, the company is currently focusing on expansion in EMEA through partnerships with leading healthcare information systems (HIS) vendors and biomedical device manufacturers across the region. Capsule’s innovative software and hardware products automate the charting process and improve clinical workflow by seamlessly connecting medical devices to information systems across the entire healthcare enterprise. Automation of this process recovers nursing hours, improves direct patient care time, reduces charting errors, improves decision making, and increases the adoption of the EMR.
The French company EuroBioConcept is a world-renowned French isolators designer and manufacturer as well as airtight transfer systems and PSM III for pharmacies, pharmaceutical industry and research laboratories. EuroBioConcept designed Chemosafe™ to ensure total protection for operators and products, to cut operating costs and to provide secure waste management. EuroBioConcept offers turn-key solutions that meet its customers’ specific needs as well as regulatory requirements (most recently for the prestigious Curie Institute). All of its devices are developed and assembled inside its own workshops.
Chemosafe™ serving the automated production of cytotoxic drugs
The Curie Institute wanted to validate and integrate an automated system within its pharmacy department in order to improve safety in antineoplastic agent reconstitution. The Institute was pleased with an automated device installed inside an isolator, a solution suggested by EuroBioConcept in association with automaton manufacturers Medical Dispensing System. Both companies then manufactured and delivered a functional unit that was to be validated within a year.
AQUAROLL SAS will showcase its innovative Aquaroll® Bead Hydromassage System at ARAB HEALTH in Dubaï from january 23th to january 26th.
Aquaroll® is a major innovation in the field of physiotherapy, rehabilitation and sports recovery. 30 000 glass beads in motion in water offer a unique combination of frictions, percussions, kneading, pressure, hydrotherapy, reflex-therapy and thermotherapy which accelerates blood circulation and lymphatic flow ,achieve micro-mobilizations, provides various levels of compression and free-up superficial and deep muscle tensions.
Aquaroll® improves range of motion and joints suppleness
- It reduces swelling and oedema.
- It relieves pain, is efficient on algodystrophia in the cooled phase
- It improves skin trophicity ,scars appearance
- Is very efficient in draining and slimming heavy legs and swollen ankles.
Complementary to current rehabilitation and recovery protocoles, Aquaroll® speeds up the benefits obtained by traditional physiotherapy techniques